ResMed Wins Patent Infringement Lawsuit Against Chinese Manufacturer BMC Medical
PR Newswire - Tue Dec 23, 5:24PM CST
ResMed (NYSE: RMD) today announced its victory in a significant patent infringement action against Chinese medical device manufacturer BMC Medical Co., Ltd.
RMD: 57.39 (+0.40)
ResMed To Announce Second Quarter 2015 Results
PR Newswire - Thu Dec 18, 3:30PM CST
RESMED INC. (NYSE: RMD) today announced that it will report its second quarter of fiscal year 2015 results on Thursday, January 22, 2015, after the New York Stock Exchange market close. A press release with ResMed's results will be issued after 1:00 p.m. US Pacific Time and the company will host a webcast to discuss operating results and future outlook.
RMD: 57.39 (+0.40)
Zimmer Holdings Names Michael Farrell to Board of Directors
PR Newswire - Fri Dec 12, 7:00AM CST
Zimmer Holdings, Inc. (NYSE and SIX: ZMH), a global leader in musculoskeletal care, today announced that Michael J. "Mick" Farrell, Chief Executive Officer of ResMed Inc. (NYSE and ASX: RMD), has been appointed to its Board of Directors.
ZMH: 114.11 (+0.64), RMD: 57.39 (+0.40)
Technical Coverage on Health Care Equipment Equities - CareFusion, Hologic, ResMed, Stryker, and Wright Medical
PR Newswire - Tue Dec 09, 7:40AM CST
Investor-Edge has initiated coverage on the following equities: CareFusion Corporation (NYSE: CFN), Hologic Inc. (NASDAQ: HOLX), ResMed Inc. (NYSE: RMD), Stryker Corporation (NYSE: SYK), and Wright Medical Group Inc. (NASDAQ: WMGI). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Monday, December 08, 2014, the NASDAQ Composite ended at 4,740.69, down 0.84%, the Dow Jones Industrial Average declined 0.59%, to finish the day at 17,852.48, and the S&P 500 closed at 2,060.31, down 0.73%. The losses were broad based as six out of ten sectors ended the session in negative. The S&P 500 Health Care Sector Index ended the day at 820.02, up 0.33%, with the index also advancing 10.58% in the previous three months. Register for your complimentary reports on these five stocks at:
WMGI: 26.65 (-0.02), CFN: 59.18 (+0.04), RMD: 57.39 (+0.40), HOLX: 26.89 (+0.10), SYK: 96.00 (-0.61)
ResMed Unveils AirCurve 10 Series - Bringing More Therapy Choices to the ResMed Air Solutions Series
PR Newswire - Thu Dec 04, 7:00AM CST
ResMed (NYSE:RMD) is launching its new AirCurve(TM) 10 series, which includes three bilevel devices for specialized support of challenging sleep apnea cases, as well as an adaptive servo-ventilation device for patients with central sleep apnea or Cheyne-Stokes respiration.
RMD: 57.39 (+0.40)
Insider Trading Alert - SFM, PF And RMD Traded By Insiders
at The Street - Tue Dec 02, 11:22AM CST
Stocks with insider trader activity include SFM, PF and RMD
RMD: 57.39 (+0.40), PF: 35.32 (+0.13), SFM: 32.70 (+0.02)
Global Home Healthcare Market - 2014-2020 Industry Analysis
M2 - Tue Dec 02, 9:48AM CST
Research and Markets (http://www.researchandmarkets.com/research/k4nfpx/global_home) has announced the addition of the "Global Home Healthcare Market - Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" report to their offering. The global home healthcare market, by services has been segmented into rehabilitation services, respiratory therapy services, telehealth and telemedicine services, infusion therapy services and unskilled home healthcare services. The market size and forecast in terms of USD million for each service has been provided for the period 2012 to 2020, considering 2013 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2014 to 2020 for each segment. Geographically, the global home healthcare systems market has been segmented into four major regions: North America, Europe, Asia Pacific and Rest of the World (RoW). The market size and forecast for each geography has been estimated for the period 2012 to 2020 in terms of revenue (USD million), considering 2013 as the base year. The report also provides the compounded annual growth rate (CAGR %) during the forecast period from 2014 to 2020 for all the geographies mentioned above. The market overview section of the report discusses the market dynamics with respect to the market drivers, restraints and opportunities. This section also covers market attractiveness analysis, event impact and value chain analysis of the global home healthcare market. Market share (%) of major players operating in the market has also been provided for the year 2013, followed by a list of recommendations for existing and new players to enter and enhance market share. The report concludes with company profiles of key players operating in various segments of the market. Each company profile includes business overview, financial overview, product portfolio, business strategies and recent developments of the respective company. Scope of the Report Global Home Healthcare Market, by Device Types Diagnostics and Monitoring Home Devices - Blood Glucose Monitors - Blood Pressure Monitors - Heart Rate Monitors - Temperature Monitors - Sleep Apnea Monitors - Coagulation Monitors - Pregnancy Test Kits - Pulse Oximeters - Pedometers Therapeutics Home Healthcare Devices - Insulin Delivery Devices - Nebulizers - Ventilator and CPAP Devices - IV Equipments - Dialysis Equipment Home Mobility Assist Devices - Wheelchairs - Cranes and Crutches - Other Home Mobility Assist Devices Medical Supplies Global Home Healthcare Market, by Services - Rehabilitation Services - Telehealth and Telemedicine Services - Infusion Therapy Services - Respiratory Therapy Services - Unskilled Home Healthcare Services Companies Mentioned - 3M Healthcare - Abbott Laboratories - Bayer AG - Becton, Dickinson and Company - Cardinal Health - F. Hoffmann-La Roche Ltd. - GE Healthcare - Gentiva Health Services, Inc. - Invacare Corporation - Johnson & Johnson Services, Inc. - Medtronic, Inc. - Omron Healthcare, Inc. - Philips Healthcare - Praxair Technologies, Inc. - ResMed, Inc. - Sunrise Medical LLC - Teleflex Incorporated - The Linde Group For more information visit http://www.researchandmarkets.com/research/k4...lobal_home
JNJ: 104.59 (+0.31), ABT: 45.70 (-0.02), MDT: 74.08 (+0.31), IVC: 16.80 (+0.20), RMD: 57.39 (+0.40), TFX: 116.82 (+0.28), GTIV: 19.07 (unch)
Australia Respiratory Devices Market Report, 2006 - 2019
M2 - Mon Dec 01, 9:46AM CST
Research and Markets (http://www.researchandmarkets.com/research/hw4pnn/australia) has announced the addition of the "Australia Respiratory Devices Market Report, 2006 - 2019" report to their offering. The Market Intelligence report provides critical market data for Australia respiratory devices market and its product categories. The data includes market size in terms of value and volume; average selling price for each product type, growth trends and market shares of companies at sector and category level. It's vital cross category comparison and cross sub-category comparison section makes analysis very handy for company professionals. The report helps professionals in mapping market size, competition, understanding historic and future growth trends. It covers important categories such as positive airway pressure devices, humidifiers, oxygen concentrator, ventilators, respiratory disposables, and respiratory measurement devices. Respiratory Devices Market Segmentation - Positive Airway Pressure Devices - Continuous Positive Airway Pressure (CPAP) - Bi-level Positive Airway Pressure (BPAP) - Automatic Positive Airway Pressure (APAP) - Humidifiers - Oxygen Concentrator - Portable Oxygen Concentrators - Fixed Oxygen Concentrators - Reusable Resuscitators - Ventilators - General Ventilators - Neonatal Ventilators - Nebulizers - Portable Jet Nebulizers - Portable Ultrasonic Nebulizers - Respiratory Disposables - Oxygen Masks - Disposable Resuscitators - Respiratory Measurement Devices - Capnograph - Pulse Oximeter Systems - Table Top Pulse Oximeter - Hand Held Pulse Oximeter - Pulse Oximeter Sensors - Spirometers Key Topics Covered: 1 Tables & Charts 2 Introduction 3 Scope of the Report 4 Australian Market for Respiratory Devices (2006-2019) 5 Argentinean Market for Positive Airway Pressure Devices (2006-2019) 6 Argentinean Market for Humidifiers (2006-2019) 7 Argentinean Market for Oxygen Concentrators (2006-2019) 8 Argentinean Market for Ventilators (2006-2019) 9 Argentinean Market for Nrbulizers (2006-2019) 10 Argentinean Market for Respiratory Disposables (2006-2019) 11 Argentinean Market for Respiratory Measurement Devices (2006-2019) 12 Recent Events and Developments 13 Appendix Companies Mentioned - Cardinal Health, Inc. - Covidien Ltd. - Drager Medical AG & Co. KG - Fisher & Paykel Healthcare Corporation Limited - GE Healthcare - Intersurgical Ltd. - Laerdal Medical As - MAQUET GmbH & Co. KG - Philips Medical Systems - ResMed Inc. - Smiths Medical - Teleflex Incorporated - Unomedical Pty Ltd For more information visit http://www.researchandmarkets.com/research/hw4pnn/australia
CAH: 82.07 (+0.15), RMD: 57.39 (+0.40), COV: 103.35 (+0.57), TFX: 116.82 (+0.28)
Latin America Home Healthcare Market - Industry Analysis 2014 - 2020
M2 - Thu Nov 27, 3:26AM CST
Research and Markets (http://www.researchandmarkets.com/research/fgc9q4/latin_america) has announced the addition of the "Latin America Home Healthcare Market - Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" report to their offering. The Latin America home healthcare market is estimated to be USD 9.7 billion in 2013 and is expected to reach USD 17.55 billion by 2020, growing at a CAGR of 8.7% from 2014 to 2020 Home healthcare devices and services help the patients to be self-sufficient towards their health. This is been increasingly accepted by the patient population owing to its cost effective nature, less number of visits to hospital and patient comfort. The Latin America home healthcare market has witnessed significant growth in the past due to factors such as increasing number of patients diagnosed with chronic diseases like diabetes, cardiac disorders, respiratory diseases and others. At the same time, economic instability and reimbursement issues related to home healthcare services are the factors restraining the market growth during the forecast period from 2014 to 2020. This report provides an in-depth and comprehensive analysis of the Latin America home healthcare market on the basis of device types, services and the major Latin American geographies. In device types segment, the report covers different types of diagnostic and monitoring devices, therapeutic devices, medical supplies and home mobility assist devices that are used by the patients. Diagnostics and monitoring devices segment includes devices such as blood glucose monitors, blood pressure monitors, sleep apnea monitors, pregnancy test kits, pulse oximeters, heart rate monitors, temperature monitors, pedometers and coagulation monitors. Therapeutic devices segment comprises insulin delivery devices, nebulizers, ventilators and CPAP devices, IV equipment and dialysis equipment. The home mobility assist devices segment is further categorized as wheelchairs, cranes and crutches and other mobility assist devices and medical supplies segment includes feeding tubes and syringes. The market size and forecast for each device type has been provided for the period 2012 to 2020, considering 2013 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2014 to 2020 for each segment. The Latin American home healthcare market is segmented as follows: Latin American Home Healthcare Market, by Device Types - Diagnostics and Monitoring Home Devices - Blood Glucose Monitors - Blood Pressure Monitors - Heart Rate Monitors - Temperature Monitors - Sleep Apnea Monitors - Coagulation Monitors - Pregnancy Test Kits - Pulse Oximeters - Pedometers - Therapeutics Home Healthcare Devices - Insulin Delivery Devices - Nebulizers - Ventilator and CPAP Devices - IV Equipments - Dialysis Equipment - Home Mobility Assist Devices - Wheelchairs - Cranes and Crutches - Other Home Mobility Assist Devices - Medical Supplies Latin American Home Healthcare Market, by Services - Rehabilitation Services - Telehealth and Telemedicine Services - Infusion Therapy Services - Respiratory Therapy Services - Unskilled Home Healthcare Services Companies Mentioned - 3M Healthcare - Abbott Laboratories - Bayer AG - Cardinal Health - F. Hoffmann-La Roche Ltd. - GE Healthcare - Gentiva Health Services, Inc. - Invacare Corporation - Johnson & Johnson Services, Inc. - Medtronic, Inc. - Omron Healthcare, Inc. - Philips Healthcare - Praxair Technologies, Inc. - ResMed, Inc. - Teleflex Incorporated - The Linde Group For more information visit http://www.researchandmarkets.com/research/fg...in_america
JNJ: 104.59 (+0.31), ABT: 45.70 (-0.02), MDT: 74.08 (+0.31), IVC: 16.80 (+0.20), RMD: 57.39 (+0.40), TFX: 116.82 (+0.28), GTIV: 19.07 (unch)
July 2015 Options Now Available For ResMed (RMD)
DividendChannel.com - Mon Nov 24, 11:53AM CST
Investors in ResMed Inc. saw new options become available today, for the July 2015 expiration.
RMD: 57.39 (+0.40)
Time to Sell These 5 'Toxic' Stocks: Bitauto Holdings and More
at The Street - Fri Nov 21, 7:41AM CST
For investors looking to buy one of these positions, it makes sense to wait for more favorable technical conditions (and a lower share price) before piling in.
ASX: 6.27 (+0.02), KMT: 36.16 (-0.20), UPL: 13.32 (-0.49), RMD: 57.39 (+0.40), BITA: 72.57 (+0.36)
ResMed: Growing Addressable Market But Possible Developing Product Commoditization
Investing Doc - at Seeking Alpha - Thu Nov 20, 1:04PM CST
RMD: 57.39 (+0.40)
ResMed Strong on Q1 Results, Huge OSA Market Potential - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 19, 2:00PM CST
On Nov 18, 2014, we issued an updated research report on ResMed, Inc. (RMD).
BSX: 13.13 (+0.07), ABAX: 58.48 (+0.22), RMD: 57.39 (+0.40), NEOG: 48.21 (-0.10)
ResMed's New S+ Consumer Sleep Monitor Now Integrates With Apple HealthKit
PR Newswire - Tue Nov 18, 7:00AM CST
ResMed (NYSE: RMD), a leading innovator in sleep, recently launched the all-new S+, the world's first non-contact, personal sleep monitoring device. ResMed today announced S+ availability through Apple retail stores in the United States and from the Apple Online Store (www.apple.com). The free S+ by ResMed App now integrates with Apple HealthKit in iOS8 to give consumers an easy-to-read, daily snapshot of their overall health and fitness. The user report can also be shared with health care providers.
RMD: 57.39 (+0.40)
ResMed Earnings In Retrospect: Up 7.2% in the Last 18 Days (RMD)
Comtex SmarTrend(R) - Mon Nov 10, 8:31AM CST
When ResMed (NYSE:RMD) reported earnings two weeks ago on October 23rd, 2014, analysts, on average, expected the company to report earnings of $0.58 on sales of $375.1 million. ResMed actually reported earnings of $0.58 per share on sales of $380.4 million, missing EPS estimates by $0.00 and beating revenue estimates by $5.3 million. Shares of ResMed have climbed from $47.70 to $51.14, representing a gain of 7.2% since the company reported earnings 18 days ago.
RMD: 57.39 (+0.40)
Health Care Equipment Stocks Technical Insight - Medtronic, Abbott Laboratories, Hologic, ResMed, and Covidien
PR Newswire - Fri Oct 31, 8:05AM CDT
Investor-Edge has initiated coverage on the following equities: Medtronic Inc. (NYSE: MDT), Abbott Laboratories (NYSE: ABT), Hologic Inc. (NASDAQ: HOLX), ResMed Inc. (NYSE: RMD), and Covidien PLC (NYSE: COV). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Thursday, October 30, 2014, ended on a positive note as the Dow Jones Industrial Average finished at 17,195.42, up 1.30% and the NASDAQ Composite closed at 4,566.14, up 0.37%. The S&P 500 finished the session 0.62% higher at 1,994.65. During the trading session, nine out of ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 774.91, up 1.81%, with the index gaining 7.78% in the previous three months. Register for your complimentary reports on these five stocks at:
ABT: 45.70 (-0.02), MDT: 74.08 (+0.31), COV: 103.35 (+0.57), RMD: 57.39 (+0.40), HOLX: 26.89 (+0.10)
Why Nintendo and Microsoft Are Diving Head-First Into the Health-Tech Business
at The Street - Thu Oct 30, 11:42AM CDT
Band will do battle with wearables from Apple, Samsung, Sony and others. Nintendo is working on a different type of device.
T: 33.96 (-0.07), S: 4.19 (-0.05), RMD: 57.39 (+0.40), ARMH: 46.80 (+0.46), SNE: 21.32 (+0.46), TMUS: 26.67 (+0.07), MSFT: 48.14 (-0.31), VZ: 47.67 (unch), AAPL: 112.01 (-0.53)
Sleep Apnea Diagnostic and Therapeutic Devices - 2014 Global Strategic Business Report
M2 - Thu Oct 30, 6:19AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qbnnd7/sleep_apnea) has announced the addition of the "Sleep Apnea Diagnostic and Therapeutic Devices - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 71 companies including many key and niche players such as: - Cadwell Laboratories, Inc. - CareFusion Corporation - Cleveland Medical Devices, Inc. - Compumedics Ltd. - DeVilbiss Healthcare - Global Medical Holdings LLC - Fisher & Paykel Healthcare Limited - GE Healthcare - Itamar Medical Ltd. - Invacare Corporation - Natus Medical Inc. - Embla Systems, Inc. - Grass Technologies - Philips Healthcare - ResMed Inc. - Teleflex Medical - Weinmann Ger?te f?r Medizin GmbH CCo. KG Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Market Overview 2. Market Trends And Dynamics 3. Sleep Apnea - A Synopsis 4. Sleep Apnea Diagnostic And Therapeutic Devices 5. Research Findings In Recent Past 6. Product Launches/Introductions 7. Recent Industry Activity 8. Focus On Select Players 9. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Middle East And Africa IV. Competitive Landscape Total Companies Profiled: 71 (including Divisions/Subsidiaries - 76) - The United States (48) - Canada (4) - Japan (1) - Europe (12) - - Germany (3) - - The United Kingdom (2) - - Italy (2) - - Spain (2) - - Rest of Europe (3) - Asia-Pacific (Excluding Japan) (
BABY: 36.45 (+1.14), IVC: 16.80 (+0.20), RMD: 57.39 (+0.40)
ResMed Posts In-Line Earnings on Revenue Beat in Q1 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 8:50AM CDT
Following the earnings release, ResMed's (RMD) share price rose 9.1% to close at $52.02 on Friday.
ZLTQ: 28.73 (-0.19), GWPH: 68.08 (+1.82), ABAX: 58.48 (+0.22), RMD: 57.39 (+0.40)
Strength Seen in ResMed (RMD): Stock Gains 9.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 8:46AM CDT
ResMed (RMD) was a big mover last session, with shares rising just over 9% on the day.
ICUI: 83.38 (+1.63), ZLTQ: 28.73 (-0.19), ABAX: 58.48 (+0.22), RMD: 57.39 (+0.40)